Medicare Enrolled
Dr. Mitchell Efros, MD
Urology Physician · Garden City, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Efros from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Efros?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Efros
Dr. Mitchell Efros is an urology physician in Garden City, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Efros performed 8,599 Medicare services across 5,367 unique beneficiaries.
Between the years covered by Open Payments, Dr. Efros received a total of $11,175 from 53 pharmaceutical and/or device companies across 371 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Efros is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 10% volume in NY
$11,175 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,599
Medicare services
Top 10% in NY for urology physician
5,367
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~430 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,751 | $2 | $8 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
1,425 | $10 | $48 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
1,308 | $8 | $24 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
946 | $112 | $441 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
807 | $77 | $313 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
417 | $8 | $26 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
265 | $8 | $24 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
265 | $8 | $24 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
163 | $32 | $227 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
158 | $7 | $154 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
135 | $145 | $579 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
127 | $226 | $1,000 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
102 | $8 | $9 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 93 | $136 | $758 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
82 | $327 | $1,305 |
| Other procedure on male genital system A surgical or medical intervention performed on the male genital organs that does not fall under other specific categories. |
81 | $268 | $1,305 |
| Antimicrobial drug detection test A laboratory test used to identify the presence of antibiotics, antifungals, or antivirals in a sample. |
81 | $5 | $14 |
| PSA test (prostate cancer screening) | 75 | $18 | $55 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
49 | $59 | $220 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
45 | $33 | $121 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
37 | $161 | $617 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
36 | $53 | $198 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
28 | $13 | $49 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
25 | $100 | $394 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
24 | $57 | $209 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
23 | $127 | $495 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
21 | $83 | $460 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
18 | $305 | $1,318 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
12 | $189 | $691 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,175
Total received (2018-2024)
Avg $1,596/year across 7 years
Top 17% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
371
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,499 (67.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,500 (31.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$175 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,052
2023
$1,464
2022
$4,743
2021
$1,202
2020
$395
2019
$953
2018
$1,367
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$202
Sumitomo Pharma America, Inc.
$186
Janssen Biotech, Inc.
$171
Axonics, Inc.
$149
Astellas Pharma US Inc
$104
Teleflex LLC
$49
Tolmar, Inc.
$43
PFIZER INC.
$42
UROGEN PHARMA, INC.
$40
CIVCO Medical Instruments
$25
Dendreon Pharmaceuticals LLC
$23
Laborie Medical Technologies Corp.
$19
Top 3 companies account for 53.1% of 2024 payments
All-time payments by company (2018-2024) ›
IBSA Institut Biochimique SA
$3,500
Astellas Pharma US Inc
$1,353
Janssen Biotech, Inc.
$908
NeoTract Inc.
$457
PFIZER INC.
$427
Sumitomo Pharma America, Inc.
$416
Myovant Sciences Inc.
$385
ABBVIE INC.
$298
AbbVie Inc.
$239
Cook Medical LLC
$195
Axonics, Inc.
$183
Coloplast Corp
$183
PROCEPT BioRobotics Corporation
$178
Endo Pharmaceuticals Inc.
$169
UroGen Pharma, Inc.
$148
Teleflex LLC
$117
Antares Pharma, Inc.
$115
TOLMAR Pharmaceuticals, Inc.
$113
Myriad Genetic Laboratories, Inc.
$112
Janssen Products, LP
$99
Progenics Pharmaceuticals, Inc.
$96
Dendreon Pharmaceuticals LLC
$91
AbbVie, Inc.
$89
Amgen Inc.
$87
Blue Earth Diagnostics Limited
$79
Allergan Inc.
$77
Allergan, Inc.
$73
EMD Serono, Inc.
$71
Tolmar, Inc.
$69
UROVANT SCIENCES INC
$62
COLOPLAST CORP
$60
Acerus Pharmaceuticals Corporation
$57
MEDIVATION FIELD SOLUTIONS LLC
$54
Bayer HealthCare Pharmaceuticals Inc.
$51
Hollister Incorporated
$49
GE HEALTHCARE
$44
Palette Life Sciences, Inc.
$43
Merck Sharp & Dohme LLC
$41
UROGEN PHARMA, INC.
$40
Olympus America Inc.
$36
Ferring Pharmaceuticals Inc.
$33
Avadel Specialty Pharmaceuticals, LLC
$32
Medtronic USA, Inc.
$31
Laborie Medical Technologies Corp.
$31
Mission Pharmacal Company
$28
CIVCO Medical Instruments
$25
Boston Scientific Corporation
$24
Accord Healthcare, Inc.
$22
DENTSPLY IH Inc.
$20
BOSTON SCIENTIFIC CORPORATION
$17
Rochester Medical Corporation
$17
ABC Home Medical Supply, Inc.
$16
Mylan Institutional Inc.
$15
Top 3 companies account for 51.6% of all-time payments
Associated products mentioned in payments ›
AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · AquaBeam Robotic System · Axumin · BOTOX · BOTOX THERAPEUTIC · Bavencio · Bulkamid · CAMCEVI · COOK · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENERAL BPH · INTERSTIM · JELMYTO · KEYTRUDA · LUPRON DEPOT · LoFric · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · Ogivri · Optilume BPH Drug Coated Balloon Catheter · PREMARIN · PROVENGE · PYLARIFY · Prolaris · Prolia · SPEEDICATH · SpeediCath · TOVIAZ · UROLIFT · Uribel · UroLift · UroLift System · VESICARE · VIAGRA · VaPro · VaPro Plus Pocket · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (67%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
634
Per 100K population
45.7
County median income
$143,408
Nearest hospital
LONG ISLAND JEWISH MEDICAL CENTER
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Efros is a clinical cardiology specialist, with above-average Medicare volume (top 10% in NY), with low-engagement industry engagement in the top 17% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Efros experienced with automated urinalysis?
Based on Medicare claims data, Dr. Efros performed 1,751 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Efros receive payments from pharmaceutical companies?
Yes. Dr. Efros received a total of $11,175 from 53 companies across 371 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Efros's costs compare to other urology physicians in Garden City?
Dr. Efros's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Efros) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Garden City
Browse urology physicians in Garden City ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
IBSA Institut Biochimique SA Payments to Doctors
See all physicians who received payments from IBSA Institut Biochimique SA.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology